Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019

2020 Ruan, 2020, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med, 46, 846, 10.1007/s00134-020-05991-x Aggarwal, 2020, Association of cardiovascular disease with coronavirus disease 2019 (COVID-19) Severity: A Meta-Analysis [published online ahead of print, 2020 Apr 28], Curr Probl Cardiol Gautret, 2020, Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial, Int J Antimicrol Agen, 10.1016/j.ijantimicag.2020.105949 Thome, 2013, Chloroquine: modes of action of an undervalued drug, Immunol Lett, 153, 50, 10.1016/j.imlet.2013.07.004 Ladipo, 1983, Complete heart block in chronic chloroquine poisoning, Int J Cardiol, 4, 198, 10.1016/0167-5273(83)90136-5 Lee, 2010, A case of chloroquine-induced cardiomyopathy that presented as sick sinus syndrome, Korean Circ J, 40, 604, 10.4070/kcj.2010.40.11.604 Stas, 2008, Conduction disorder and QT prolongation secondary to long-term treatment with chloroquine, Int J Cardiol, 127, e80, 10.1016/j.ijcard.2007.04.055 Costedoat-Chalumeau, 2007, Heart conduction disorders related to antimalarials toxicity: an analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases, Rheumatol (Oxford), 46, 808, 10.1093/rheumatology/kel402 Chatre, 2018, Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature, Drug Saf, 41, 919, 10.1007/s40264-018-0689-4 Reffelmann, 2006, Images in cardiovascular medicine. Contrast-enhanced magnetic resonance imaging of a patient with chloroquine-induced cardiomyopathy confirmed by endomyocardial biopsy, Circulation, 114, e357, 10.1161/CIRCULATIONAHA.105.600627 Chen, 2020, Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial, medRxiv Trifiro, 2017, Use of azithromycin and risk of ventricular arrhythmia, CMAJ, 189, E560, 10.1503/cmaj.160355 Trac, 2016, Macrolide antibiotics and the risk of ventricular arrhythmia in older adults, CMAJ, 188, E120, 10.1503/cmaj.150901 Yang, 2017, Azithromycin causes a novel proarrhythmic syndrome, Circ Arrhythm Electrophysiol, 10, 10.1161/CIRCEP.115.003560 2013, In brief: FDA azithromycin warning, Med Lett Drugs Ther, 55, 28 Ray, 2012, Azithromycin and the risk of cardiovascular death, N Engl J Med, 366, 1881, 10.1056/NEJMoa1003833 Svanstrom, 2013, Use of azithromycin and death from cardiovascular causes, N Engl J Med, 368, 1704, 10.1056/NEJMoa1300799 Rao, 2014, Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death, Ann Fam Med, 12, 121, 10.1370/afm.1601 Cheng, 2015, The role of macrolide antibiotics in increasing cardiovascular risk, J Am Coll Cardiol, 66, 2173, 10.1016/j.jacc.2015.09.029 Mulangu, 2019, A randomized, controlled trial of Ebola virus disease therapeutics, N Engl J Med, 381, 2293, 10.1056/NEJMoa1910993 Cao, 2020, A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19, N Engl J Med, 382, 1787, 10.1056/NEJMoa2001282 Limsreng, 2016, Dyslipidemias and elevated cardiovascular risk on lopinavir-based antiretroviral therapy in Cambodia, PLoS One, 11, 10.1371/journal.pone.0160306 Chaubey, 2009, Transient cardiac arrhythmias related to lopinavir/ritonavir in two patients with HIV infection, Sex Health, 6, 254, 10.1071/SH09005 Teragawa, 1996, Adverse effects of interferon on the cardiovascular system in patients with chronic hepatitis C, Jpn Heart J, 37, 905, 10.1536/ihj.37.905 Guo, 2020, The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status, Mil Med Res, 7, 11 El-Dosouky, 2016, Types and predictors of interferon/ribavirin induced cardiac complications in the Egyptian patients with chronic hepatitis C virus, J Indian Coll Cardiol, 6, 16, 10.1016/j.jicc.2016.01.001 Chinello, 2017, QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient, PLoS Negl Trop Dis, 11, 10.1371/journal.pntd.0006034 Lee, 2004, Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes?, Am J Clini Nutrit, 80, 1194, 10.1093/ajcn/80.5.1194 Bacchiega, 2017, Interleukin 6 inhibition and coronary artery disease in a high-risk population: a prospective community-based clinical study, J Am Heart Assoc, 6, 10.1161/JAHA.116.005038